Found 14 matching trials
A Proof of Concept Study to Evaluate the Effect of UB-421 in Combination With Chidamide on HIV Viral Reservoir PHASE2 * To assess the impact of UB-421 and chidamide in changing HIV-1 viral rese...
Show More Location
Multiple Locations
Learn More & Join Trial
The HIV Functional Cure Potential of UB-421 in ART Stabilized HIV-1 Patients PHASE2 This study evaluate the safety of UB-421 in combination with standard antir...
Show More Location
Kaohsiung Medical University Chung-Ho Memorial Hospital
Learn More & Join Trial
Study for Evaluation of the Safety, Pharmacokinetics, and Antiviral Activity of UB-421 Subcutaneous Formulation Administered in HIV-1 Infected Treatment Naive Patients PHASE1 This is a phase I, open-label, dose-escalation study to investigate short-t...
Show More Location
Kaohsiung Veterans General Hospital
Learn More & Join Trial
A Proof-of-concept Trial to Evaluate the Safety and Efficacy of UB-421 Plus Chidamide in Changing HIV Reservoirs PHASE2 This is a phase II proof-of-concept trial study to assess the safety and ef...
Show More Location
Kaohsiung Veterans General Hospital
Learn More & Join Trial
Study for Evaluation of the Safety, Pharmacokinetics, and Antiviral Activity of UB-421 Subcutaneous Formulation in HIV Infected Adults PHASE1 UB-421 subcutaneous formulation (UB-421 SC) is developed to provide HIV inf...
Show More Location
Multiple Locations
Learn More & Join Trial
UB-421 Combine With Optimized Background Therapy Regimen in Multi-Drug Resistant HIV-1 Infection Patients PHASE2 This is a Phase 2, multi-center study, designed to evaluate the efficacy, s...
Show More Location
Multiple Locations
Learn More & Join Trial
The HIV Functional Cure Potential of UB-421 in ART Stabilized HIV-1 Patients PHASE2 This is a Phase II, randomized, open-label, multi-center, active-controlled...
Show More Location
Multiple Locations
Learn More & Join Trial
A Trial of Anti-CD4 Antibody UB-421 in Combination With Optimized Background Antiretroviral Therapy in Patients With Multi-Drug Resistant HIV-1 Infection PHASE2 Background:
People with HIV usually take a combination of 2 or more anti-H...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Study to Evaluate Safety and Pharmacokinetics of UB-421 Antibody in HIV-1 Infected Adults PHASE1 The purpose of this Phase I study is to determine whether the antibody (UB-...
Show More Location
Taipei Veterans General Hospital (TVGH)
Learn More & Join Trial
UB-421 in Combination With Optimized Background Regimen in Patients With Multi-drug Resistant HIV-1 Infection PHASE3 The purpose of this phase III study is to evaluate the efficacy between tre...
Show More Location
Multiple Locations
Learn More & Join Trial